Category Archives: BioUtah News
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis Down to Age 2
Indication expansion addresses a major pediatric gap where topical corticosteroids are commonly used off-label yet constrained by sensitive-site and long-term continuous-use limitations.
Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
Virtual health platform offers an additional pathway to care for the more than 45 million people in the U.S. living with eczema, seborrheic dermatitis, and plaque psoriasis.
Early-Phase Data Support Novel Contrast Agent
ASE 2026 data support further development of MVT-100 in pivotal trials.
bioMérieux Seeks FDA Authorization for Point-of-Care Vaginitis Test
The automated PCR test provides results in 20 minutes to help clinicians diagnose common causes of vaginitis during a patient visit.
NUSANO COMPLETES MAJOR MILESTONE TOWARD COMMERCIAL RADIOISOTOPE PRODUCTION
FIRST OF THREE STEPS TOWARD BRINGING NOVEL RADIOISOTOPE PRODUCTION PLATFORM ONLINE
Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel
Novel gel embolic designed to give physicians greater control and consistency during embolization.
Elevating Utah’s Bioscience Advantage at BIO 2026
BioUtah, alongside state and local partners, showcased Utah’s booming $22.6B+ life sciences sector at the BIO International Convention, June 22-25, at the San Diego Convention Center. Through the Utah Pavilion Exhibit, the delegation boosted the state’s global profile as a premier bioscience hub. A number of meetings with entrepreneurs and companies interested in Utah’s bio […]
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
SINTX’s advanced ceramic manufacturing platform supports customers across multiple industries requiring high-performance materials.
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY
Aligns With Growing Focus on Early Identification and Management of Preterm Birth Risk
Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
Canary Speech Brings Canary Ambient™ to the Zoom App Marketplace, Putting Real-Time Vocal Biomarker Insights Into Every Telehealth Visit
AI-powered voice analysis is now available to clinicians directly inside Zoom, transforming routine telehealth conversations into early signals for behavioral and cognitive health
BioUtah and Utah’s Life Sciences Industry Take Center Stage with Pavilion at BIO International Convention
The Utah Pavilion will serve as a gathering place to help convention attendees discover the state’s vibrant life sciences industry and the sector’s unique culture of collaboration that drives innovation.
